September 14—Baltimore, Maryland— Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
Scheril Murray Powell, Esq., SMP LAW/Creative Services, will give a keynote talk tomorrow in the hemp room 308 at 2:40 p.m. The talk is titled “Navigating the Evolving Needs of a Global Cannabis Company as In House Counsel.”
The role of in-house counsel varies in responsibilities, in some companies the focus is on litigation related activities, in others the focus is on compliance and government relations. It is not unusual for the in-house counsel to also work closely with the CEO and HR teams on employee issues. The start-up cannabis company has many needs, but also has evolving needs. The role of in-house counsel may start out in an advisory role to the CEO acting as a Swiss army knife of functionality on any topic that comes up. As the company grows, the needs will change and more narrowly focused, strategic activity for the in-house counsel will. This discussion will cover the varied and evolving in-house counsel role.
Scheril Murray Powell, Esq., is an agricultural, cannabis, and dietary supplement attorney at Doumar, Allsworth, Laystrom, Voigt, Adair, and Dishowitz LLP. Scheril also serves as the Director of Business Development of Creative Services, a FCRA compliance, background screening, and security firm. The Daily Business Review has named her one of the Top 12 cannabis attorney’s in Florida. Her practice covers both the marijuana and hemp industries, specializing in cannabinoid legalization and UK novel foods registration.
For more information on the hemp track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.